Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro.
about
Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's diseaseGlyceraldehyde-3-phosphate dehydrogenase-monoamine oxidase B-mediated cell death-induced by ethanol is prevented by rasagiline and 1-R-aminoindan.Effects of rasagiline, its metabolite aminoindan and selegiline on glutamate receptor mediated signalling in the rat hippocampus slice in vitro.Therapeutic advances in multiple system atrophy and progressive supranuclear palsy.Protein kinase Cepsilon: the mitochondria-mediated signaling pathway.Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease.Pharmacological therapy in Parkinson's disease: focus on neuroprotection.The role of rasagiline in the treatment of Parkinson's disease.Explaining ADAGIO: a critical review of the biological basis for the clinical effects of rasagiline.Designing drugs with multi-target activity: the next step in the treatment of neurodegenerative disorders.Revelation in the neuroprotective functions of rasagiline and selegiline: the induction of distinct genes by different mechanisms.Pharmacokinetic/pharmacodynamic evaluation of rasagiline mesylate for Parkinson's disease.Rasagiline and rapid symptomatic motor effect in Parkinson's disease: review of literature.Neuroprotective Effects of Loganin on MPTP-Induced Parkinson's Disease Mice: Neurochemistry, Glial Reaction and Autophagy Studies.Use of monoamine oxidase inhibitors in chronic neurodegeneration.C-terminal mechano-growth factor induces heme oxygenase-1-mediated neuroprotection of SH-SY5Y cells via the protein kinase Cϵ/Nrf2 pathway.Rasagiline protects against alpha-synuclein induced sensitivity to oxidative stress in dopaminergic cells.Multi target neuroprotective and neurorestorative anti-Parkinson and anti-Alzheimer drugs ladostigil and m30 derived from rasagiline.Comparative neuroprotective effects of rasagiline and aminoindan with selegiline on dexamethasone-induced brain cell apoptosis.Successful use of rasagiline in combination with two antidepressants: a case report.Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline.Protocatechualdehyde Protects Against Cerebral Ischemia-Reperfusion-Induced Oxidative Injury Via Protein Kinase Cε/Nrf2/HO-1 Pathway.Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration.
P2860
Q27301283-55F1368E-E250-43DA-906F-BBBDCB4BD1D0Q33821908-0F8F8471-136C-4734-AAC9-71FA502DBFA9Q33825775-7D6CAD38-5FDF-4146-B1F5-65D890292D34Q34487619-BE10C22D-DC5D-46B1-8736-E81F89F154CFQ37219736-BC78BA2A-2483-4C49-B695-DA7AAFAC1FE4Q37578490-AF3F5205-568C-4A6E-82DF-4C8A7CC264F1Q37741285-0DE6828B-F8A4-40CA-B3AC-D0FDFF677216Q37762167-11CCB46C-3041-41DC-B404-6FDB70FA4F76Q37939755-42B521FE-D6A0-4692-BA81-4E61BE4A4F8AQ38066606-884BC384-BBF0-4DBB-AA8C-88A97DA9723DQ38112214-F054F0A8-F684-4F10-90D6-71F3F71DC3ACQ38246682-357B0334-CE32-4BD3-8C4B-B91693074B1AQ38497529-63340565-B14D-4AF5-929F-C52D65FDEF0DQ38740508-3FA35555-837A-45EB-A50A-982485E40FB2Q39044780-08F0B026-E8E3-4B00-A728-7CC58D9C0AACQ39603952-820A83E9-ED07-4AE0-BA41-E602444571BFQ39681299-2767036B-60FB-4CB0-AC15-9ADC0F60BB1AQ39694072-2D39B604-A24E-4685-9DB1-04C9E9FDC80BQ42573791-2CAD64FF-973D-4DD2-90AE-0567A965B031Q42932271-5C6D060E-753D-4B9B-84BA-B3C881DD5D7DQ43073052-C5409B5E-C943-4E83-9F58-9A4412D0CD08Q46609197-20F4C3F7-59BA-4D32-9C91-922D8C8617C9Q46654865-3FFD68D5-C4F1-4245-8644-EB43CBC1BD2A
P2860
Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Aminoindan and hydroxyaminoind ...... rotective properties in vitro.
@ast
Aminoindan and hydroxyaminoind ...... rotective properties in vitro.
@en
Aminoindan and hydroxyaminoind ...... rotective properties in vitro.
@nl
type
label
Aminoindan and hydroxyaminoind ...... rotective properties in vitro.
@ast
Aminoindan and hydroxyaminoind ...... rotective properties in vitro.
@en
Aminoindan and hydroxyaminoind ...... rotective properties in vitro.
@nl
prefLabel
Aminoindan and hydroxyaminoind ...... rotective properties in vitro.
@ast
Aminoindan and hydroxyaminoind ...... rotective properties in vitro.
@en
Aminoindan and hydroxyaminoind ...... rotective properties in vitro.
@nl
P2093
P1476
Aminoindan and hydroxyaminoind ...... rotective properties in vitro.
@en
P2093
Moussa B H Youdim
Orit Bar-Am
Tamar Amit
P304
P356
10.1111/J.1471-4159.2007.04777.X
P407
P577
2007-07-17T00:00:00Z